Recent advances in laboratory diagnosis of human cytomegalovirus infection

Clinical and Applied Immunology Reviews

Volumn 2, Issue 3, 2002, Pages 155-167

  Yan, Steve ^a   Fedorko, Daniel P ^b  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Antigenemia; Culture; Human cytomegalovirus; Laboratory diagnosis; Molecular methodology; Serodiagnostics

Indexed keywords

IMMUNOGLOBULIN G; MESSENGER RNA; VIRUS ANTIGEN; VIRUS DNA; VIRUS RNA;

ANTIBODY DETECTION; ANTIGEN BINDING; ANTIGEN DETECTION; BINDING ASSAY; CONGENITAL INFECTION; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE AMPLIFICATION; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNE DEFICIENCY; LABORATORY AUTOMATION; LABORATORY DIAGNOSIS; LEUKOCYTE; POLYMERASE CHAIN REACTION; PREDICTION; QUANTITATIVE ANALYSIS; REVIEW; RNA HYBRIDIZATION; RNA PROBE; SERODIAGNOSIS; VIRUS CULTURE; VIRUS REACTIVATION;

EID: 0036625872     PISSN: 15291049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1529-1049(02)00045-4     Document Type: Review

References (51)

1. Rawlinson WD. Broadsheet. Number 50: diagnosis of human cytomegalovirus infection and disease. Pathology 1999;31:109-15.
2. Grangeot-Keros L, Cointe D. Diagnosis and prognostic markers of HCMV infection. J Clin Virol 2001;21:213-21.
3. Greijer AE, van de Crommert JM, Stevens SJ, Middeldorp JM. Molecular fine-specificity analysis of anti-body responses to human cytomegalovirus and design of novel synthetic-peptide-based serodiagnostic assays. J Clin Microbiol 1999;37:179-88.
4. Hodinka RL. Human cytomegalovirus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. Washington, DC, ASM Press, 1999:888-99.
5. Stagno S, Tinker MK, Elrod C, Fuccillo DA, Cloud G, O'Beirne AJ. Immunoglobulin M antibodies detected by enzyme-linked immunosorbent assay and radioimmunoassay in the diagnosis of cytomegalovirus infections in pregnant women and newborn infants. J Clin Microbiol 1985;21:930-5.
6. Hedman K, Lappalainen M, Söderlund M, Hedman L. Avidity if IgG in serodiagnosis of infectious diseases. Rev Med Microbiol 1993;4:123-9.
7. Bodeus M, Feyder S, Goubau P. Avidity of IgG antibodies distinguishes primary from non-primary cytomegalovirus infection in pregnant women. Clin Diagn Virol 1998;9:9-16.
8. Bodeus M, Goubau P. Predictive value of maternal-IgG avidity for congenital human cytomegalovirus infection. J Clin Virol 1999;12:3-8.
9. Grangeot-Keros L, Mayaux MJ, Lebon P, Freymuth F, Eugene G, Stricker R, et al. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J Infect Dis 1997;175:944-6.
10. Baccard-Longere M, Freymuth F, Cointe D, Seigneurin JM, Grangeot-Keros L. Multicenter evaluation of a rapid and convenient method for determination of cytomegalovirus immunoglobulin G avidity. Clin Diagn Lab Immunol 2001;8:429-31.
11. Lazzarotto T, Galli C, Pulvirenti R, Rescaldani R, Vezzo R, La Gioia A, et al. Evaluation of the Abbott Ax-SYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay. Clin Diagn Lab Immunol 2001;8:196-8.
12. Gleaves CA, Smith TF, Shuster EA, Pearson GR. Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens. J Clin Microbiol 1985;21:217-21.
13. Paya CV, Wold AD, Smith TF. Detection of cytomegalovirus infections in specimens other than urine by the shell vial assay and conventional tube cell cultures. J Clin Microbiol 1987;25:755-7.
14. Monte PD, Lazzarotto T, Ripalti A, Landini MP. Human cytomegalovirus infection: a complex diagnostic problem in which molecular biology has induced a rapid evolution. Intervirology 1996;39:193-203.
15. Boeckh M, Boivin G. Quantitation of cytomegalovirus: methodologic aspects and clinical applications. Clin Microbiol Rev 1998;11:533-54.
16. Gerna G, Zavattoni M, Baldanti F, Furione M, Chezzi L, Revello MG, et al. Circulating cytomegalic endothelial cells are associated with high human cytomegalovirus (HCMV) load in AIDS patients with late-stage disseminated HCMV disease. J Med Virol 1998;55:64-74.
17. van den Berg AP, Harmsen MC, van der Bij W, van Son WJ. The cytomegalovirus antigenemia assay: a plea for standardization. Scand J Infect Dis Suppl 1995;99:25-9.
18. Baldanti F, Revello MG, Percivalle E, Gerna G. Use of the human cytomegalovirus (HCMV) antigenemia assay for diagnosis and monitoring of HCMV infections and detection of antiviral drug resistance in the immunocompromised. J Clin Virol 1998;11:51-60.
19. Boeckh M, Bowden RA, Goodrich JM, Pettinger M, Meyers JD. Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. Blood 1992;80:1358-64.
20. Boland GJ, Mesker WE, Doorn R, Ploem-Zaaijer JJ, Tank HJ, de Gast GC. Detection improvement of cytomegalovirus antigen in human peripheral blood using monoclonal antibodies and automated reading of cell preparations. Eur J Clin Invest 1995;25:639-46.
21. Honda J, Okubo Y, Imamura Y, Kusaba M, Saruwatari N, Oizumi K. Flow cytometric detection of cytomegalovirus antigen in peripheral blood cells after bone marrow transplantation. Br J Haematol 1997;99:415-7.
22. Imbert-Marcille BM, Robillard N, Poirier AS, Coste-Burel M, Cantarovich D, Milpied N, et al. Development of a method for direct quantification of cytomegalovirus antigenemia by flow cytometry. J Clin Microbiol 1997;35:2665-9.
23. Poirier-Toulemonde AS, Milpied N, Cantarovich D, Morcet JF, Billaudel S, Imbert-Marcille BM. Clinical relevance of direct quantification of pp65 antigenemia using flow cytometry in solid organ and stem cell transplant recipients. J Clin Microbiol 2000;38:3143-9.
24. Essa S, Pacsa AS, Al-Attiyah R, El-Shazly A, Raghupathy R, Said T. The use of flow cytometry for the detection of CMV-specific antigen (pp65) in leukocytes of kidney recipients. Clin Transplant 2000;14:147-51.
25. Avery RK, Adal KA, Longworth DL, Bolwell BJ. A survey of allogeneic bone marrow transplant programs in the United States regarding cytomegalovirus prophylaxis and pre-emptive therapy. Bone Marrow Transplant 2000;26:763-7.
26. Ho SK, Li FK, Lai KN, Chan TM. Comparison of the CMV brite turbo assay and the digene hybrid capture CMV DNA (Version 2.0) assay for quantitation of cytomegalovirus in renal transplant recipients. J Clin Microbiol 2000;38:3743-5.
27. Mazzulli T, Wood S, Chua R, Walmsley S. Evaluation of the Digene Hybrid Capture System for detection and quantitation of human cytomegalovirus viremia in human immunodeficiency virus-infected patients. J Clin Microbiol 1996;34:2959-62.
28. Mazzulli T, Drew LW, Yen-Lieberman B, Jekic-McMullen D, Kohn DJ, Isada C, et al. Multicenter comparison of the digene hybrid capture CMV DNA assay (version 2.0), the pp65 antigenemia assay, and cell culture for detection of cytomegalovirus viremia. J Clin Microbiol 1999;37:958-63.
29. Walmsley S, O'Rourke K, Mortimer C, Rachlis A, Fong I, Mazzulli T. Predictive value of cytomegalovirus (CMV) antigenemia and digene hybrid capture DNA assays for CMV disease in human immunodeficiency virus-infected patients. Clin Infect Dis 1998;27:573-81.
30. Hodinka RL. The clinical utility of viral quantitation using molecular methods. Clin Diagn Virol 1998;10:25-47.
31. Hoang MP, Dawson DB, Rogers ZR, Scheuermann RH, Rogers BB. Polymerase chain reaction amplification of archival material for Epstein-Barr virus, cytomegalovirus, human herpesvirus 6, and parvovirus B19 in children with bone marrow hemophagocytosis. Hum Pathol 1998;29:1074-7.
32. Ehrnst A. The clinical relevance of different laboratory tests in CMV diagnosis. Scand J Infect Dis Suppl 1996;100:64-71.
33. Gerna G, Baldanti F, Zella D, Furione M. Detection of human cytomegalovirus DNA: how, when and where? Scand J Infect Dis Suppl 1995;99:11-5.
34. Griscelli F, Barrois M, Chauvin S, Lastere S, Bellet D, Bourhis JH. Quantification of human cytomegalovirus DNA in bone marrow transplant recipients by real-time PCR. J Clin Microbiol 2001;39:4362-9.
35. Guiver M, Fox AJ, Mutton K, Mogulkoc N, Egan J. Evaluation of CMV viral load using TaqMan CMV quantitative PCR and comparison with CMV antigenemia in heart and lung transplant recipients. Transplantation 2001;71:1609-15.
36. Caliendo AM, St George K, Kao SY, Allega J, Tan BH, LaFontaine R, et al. Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients. J Clin Microbiol 2000;38:2122-7.
37. Boivin G, Belanger R, Delage R, Beliveau C, Demers C, Goyette N, et al. Quantitative analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay and the COBAS AMPLICOR CMV MONITOR PCR test after blood and marrow allogeneic transplantation. J Clin Microbiol 2000;38:4356-60.
38. Sia IG, Wilson JA, Espy MJ, Paya CV, Smith TF. Evaluation of the COBAS AMPLICOR CMV MONITOR test for detection of viral DNA in specimens taken from patients after liver transplantation. J Clin Microbiol 2000;38:600-6.
39. Najioullah F, Thouvenot D, Lina B. Development of a real-time PCR procedure including an internal control for the measurement of HCMV viral load. J Virol Methods 2001;92:55-64.
40. Kearns AM, Guiver M, James V, King J. Development and evaluation of a real-time quantitative PCR for the detection of human cytomegalovirus. J Virol Methods 2001;95:121-31.
41. Thaker VB, Yan SS, Fahle G, Larsen HH, Graber C, Fischer SH. Comparison of a quantitative (LightCycler) real-time PCR assay with pp65 antigenemia and Nuclisens pp67 mRNA for detection of cytomegalovirus viremia in bone marrow transplant patients, ASM General Meeting. Orlando, FL, 2001.
42. Tanaka N, Kimura H, Iida K, Saito Y, Tsuge I, Yoshimi A, et al. Quantitative analysis of cytomegalovirus load using a real-time PCR assay. J Med Virol 2000;60:455-62.
43. Machida U, Kami M, Fukui T, Kazuyama Y, Kinoshita M, Tanaka Y, et al. Real-time automated PCR for early diagnosis and monitoring of cytomegalovirus infection after bone marrow transplantation. J Clin Microbiol 2000;38:2536-42.
44. Nitsche A, Steuer N, Schmidt CA, Landt O, Ellerbrok H, Pauli G, et al. Detection of human cytomegalovirus DNA by real-time quantitative PCR. J Clin Microbiol 2000;38:2734-7.
45. Schalasta G, Eggers M, Schmid M, Enders G. Analysis of human cytomegalovirus DNA in urines of newborns and infants by means of a new ultrarapid real-time PCR-system. J Clin Virol 2000;19:175-85.
46. Gault E, Michel Y, Dehee A, Belabani C, Nicolas JC, Garbarg-Chenon A. Quantification of human cytomegalovirus DNA by real-time PCR. J Clin Microbiol 2001;39:772-5.
47. Greijer AE, Verschuuren EA, Harmsen MC, Dekkers CA, Adriaanse HM, Middeldorp JM. Direct quantification of human cytomegalovirus immediate-early and late mRNA levels in blood of lung transplant recipients by competitive nucleic acid sequence-based amplification. J Clin Microbiol 2001;39:251-9.
48. Amorim ML, Cabeda JM, Seca R, Mendes AC, Castro AP, Amorim JM. CMV infection of liver transplant recipients: comparison of antigenemia and molecular biology assays. BMC Infect Dis 2001;1:2.
49. Witt DJ, Kemper M, Stead A, Sillekens P, Ginocchio CC, Espy MJ, et al. Analytical performance and clinical utility of a nucleic acid sequence-based amplification assay for detection of cytomegalovirus infection. J Clin Microbiol 2000;38:3994-9.
50. Gerna G, Baldanti F, Lilleri D, Parea M, Alessandrino E, Pagani A, et al. Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients. J Clin Microbiol 2000;38:1845-53.
51. Blok MJ, Goossens VJ, Vanherle SJ, Top B, Tacken N, Middeldorp JM, et al. Diagnostic value of monitoring human cytomegalovirus late pp67 mRNA expression in renal-allograft recipients by nucleic acid sequence-based amplification. J Clin Microbiol 1998;36:1341-6.